nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.0904	0.0924	CbGpPWpGaD
Norgestimate—ABCC2—ABC-family proteins mediated transport—PEX19—glaucoma	0.0805	0.0822	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.0531	0.0542	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.0496	0.0506	CbGpPWpGaD
Norgestimate—ESR1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.0369	0.0377	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.0291	0.0297	CbGpPWpGaD
Norgestimate—PGR—Ovarian Infertility Genes—CCND2—glaucoma	0.0288	0.0294	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—RPTOR—glaucoma	0.027	0.0276	CbGpPWpGaD
Norgestimate—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.0245	0.0251	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptors—NR3C1—glaucoma	0.0197	0.0202	CbGpPWpGaD
Norgestimate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.0193	0.0197	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.0188	0.0192	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.0157	0.016	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.0156	0.0159	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.0134	0.0137	CbGpPWpGaD
Norgestimate—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.0131	0.0134	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.013	0.0132	CbGpPWpGaD
Norgestimate—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.0126	0.0128	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.0124	0.0127	CbGpPWpGaD
Norgestimate—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.0124	0.0127	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—SLC6A13—glaucoma	0.0118	0.0121	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.0116	0.0118	CbGpPWpGaD
Norgestimate—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.0116	0.0118	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—TXN—glaucoma	0.00972	0.00993	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.0092	0.0094	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00915	0.00935	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—SLC6A1—glaucoma	0.00866	0.00885	CbGpPWpGaD
Norgestimate—Progesterone—CYP1B1—glaucoma	0.00844	0.394	CrCbGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00841	0.00859	CbGpPWpGaD
Norgestimate—Testosterone—CYP1B1—glaucoma	0.00797	0.372	CrCbGaD
Norgestimate—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.00777	0.00794	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.00775	0.00792	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.0076	0.00777	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.00754	0.0077	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.00745	0.00761	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.00729	0.00745	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.00726	0.00742	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.0072	0.00736	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.00711	0.00726	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—TGFB2—glaucoma	0.00706	0.00721	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.00697	0.00712	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.00653	0.00667	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00632	0.00646	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.00615	0.00628	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.00606	0.00619	CbGpPWpGaD
Norgestimate—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.00594	0.00607	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.00583	0.00595	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.00579	0.00592	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.00574	0.00586	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00568	0.0058	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—BAD—glaucoma	0.00557	0.00569	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—BAD—glaucoma	0.00539	0.00551	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.00528	0.00539	CbGpPWpGaD
Norgestimate—Progesterone—NR3C1—glaucoma	0.00502	0.234	CrCbGaD
Norgestimate—ABCC2—NRF2 pathway—GSTM1—glaucoma	0.0048	0.0049	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.00477	0.00488	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.00463	0.00473	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.00449	0.00458	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.00448	0.00458	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—LRP12—glaucoma	0.00444	0.00454	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.0042	0.00429	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.0041	0.00419	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00409	0.00418	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00394	0.00402	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—TP53—glaucoma	0.0038	0.00389	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.0038	0.00388	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00379	0.00387	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.00376	0.00384	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.00363	0.00371	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.0036	0.00368	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.00353	0.00361	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.00318	0.00325	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—BAD—glaucoma	0.00317	0.00324	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.00308	0.00315	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—OPN4—glaucoma	0.00308	0.00315	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.00307	0.00314	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HEYL—glaucoma	0.00286	0.00293	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00277	0.00283	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PTGFR—glaucoma	0.00277	0.00283	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—NR3C1—glaucoma	0.00269	0.00275	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00264	0.0027	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—LRP12—glaucoma	0.00261	0.00267	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.00258	0.00263	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	0.00221	0.00225	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—RPTOR—glaucoma	0.00217	0.00222	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NCK2—glaucoma	0.0021	0.00215	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.00194	0.00198	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.00184	0.00188	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.00184	0.00188	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—OPN4—glaucoma	0.00181	0.00185	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	0.0018	0.00184	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HDAC9—glaucoma	0.00179	0.00183	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HEYL—glaucoma	0.00168	0.00172	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PTGFR—glaucoma	0.00163	0.00166	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	0.00158	0.00162	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.00153	0.00156	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—CDKN2B—glaucoma	0.00148	0.00151	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SMO—glaucoma	0.0014	0.00143	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	0.00139	0.00142	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.00131	0.00134	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—NR3C1—glaucoma	0.0013	0.00133	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NTRK2—glaucoma	0.00128	0.00131	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RPTOR—glaucoma	0.00127	0.0013	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NCK2—glaucoma	0.00123	0.00126	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.00115	0.00118	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NGFR—glaucoma	0.0011	0.00112	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HDAC9—glaucoma	0.00105	0.00107	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NTRK1—glaucoma	0.00104	0.00107	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN2B—glaucoma	0.000961	0.000982	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EDN1—glaucoma	0.000922	0.000942	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—CDKN2B—glaucoma	0.000867	0.000886	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NGF—glaucoma	0.000847	0.000866	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SMO—glaucoma	0.000821	0.000839	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—C3—glaucoma	0.000805	0.000823	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—NR3C1—glaucoma	0.000761	0.000778	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NTRK2—glaucoma	0.000751	0.000767	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—APOE—glaucoma	0.00075	0.000766	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CAV1—glaucoma	0.000743	0.000759	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FN1—glaucoma	0.000707	0.000723	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—BAD—glaucoma	0.000699	0.000714	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NGFR—glaucoma	0.000644	0.000658	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NTRK1—glaucoma	0.000612	0.000625	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN2B—glaucoma	0.000564	0.000576	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NOS3—glaucoma	0.000562	0.000574	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EDN1—glaucoma	0.000541	0.000553	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NGF—glaucoma	0.000497	0.000508	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN1B—glaucoma	0.000487	0.000497	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—C3—glaucoma	0.000473	0.000483	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—MMP9—glaucoma	0.000451	0.000461	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—APOE—glaucoma	0.00044	0.00045	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CAV1—glaucoma	0.000436	0.000446	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FN1—glaucoma	0.000415	0.000424	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—BAD—glaucoma	0.00041	0.000419	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—glaucoma	0.000405	0.000414	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NOS3—glaucoma	0.00033	0.000337	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—glaucoma	0.000306	0.000313	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN1B—glaucoma	0.000286	0.000292	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—MMP9—glaucoma	0.000265	0.00027	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—glaucoma	0.000238	0.000243	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—glaucoma	0.000179	0.000183	CbGpPWpGaD
